Markers of disease-related tissue damage in the brains of Fabry disease patients treated with Galafold (migalastat) tend to remain stable over time, a study found. Fabry patients with high blood pressure may be more likely to have damage in the brain, according…
Featured Articles
The month of January tends to make people bloom with optimism and fresh resolve to achieve their wellness goals. However, the “take control of your health” message doesn’t resonate with people with Fabry disease. This time of year is a reminder of how much is outside of a Fabry…
Despite a delayed start until adulthood, enzyme replacement therapy (ERT) was associated with long-term cardiac stability in a man with Fabry disease who had shown symptoms since early childhood, a case study from Brazil shows. Because ERT was initiated before any signs of heart involvement appeared, the man…
Nearly one in five adults with Fabry disease experienced a stroke over roughly a decade of follow-up, with risk shaped by genetic factors, kidney function, and coexisting autoimmune disease, a large U.K. study found. Preserved kidney function and carrying the disease-causing N215S mutation — which is often linked to…
Newly diagnosed? Start your journey here.
Need to know
Becoming educated and informed about Fabry disease is a good first step. Here you’ll find general information about the disease, including diagnosis, symptoms, and causes.
Personal experiences
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your Fabry disease journey.
Treatment
There is no cure for Fabry disease yet, but there are treatments that can help manage the disease. Learn more about the approved and experimental therapies here.